completely agree tanimrod and your points. I think they are valid concerns and you can't argue them.
I just think that when (not if ) we get P3 we will have multiple companies in multiple jurisdictions lining up to sign deals. Paul / simon recently talk about USA / China / South America / Middle East. all lies ? let's see.
BP need a pipeline and this is a pretty good and a pretty cheap bet for BP. they spend billions each year on pipeline.
for sure we can get delayed by the fda etc and that will be a problem. yes a CR may come. but I see a clear path if most of the stars align to get out of this mess.
and if we do ? what is a P3 potential blockbuster asset with 2-3 years to Revenue, consistent p1-2 and real world data worth in 6-12 months ? my money is on circa a billion Aussie.
if we get to that point I would hope we get a better board and ceo/chairman separation and then that noise too will hopefully subside.
we will be heading north or south soon enough. I think we know where the respective punters in this thread stand.
- Forums
- ASX - By Stock
- PAR
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-74
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $73.55M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $216.0K | 1.057M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 143324 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 44935 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 138349 | 0.200 |
9 | 191984 | 0.195 |
15 | 199884 | 0.190 |
6 | 161140 | 0.185 |
16 | 784128 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 44935 | 3 |
0.215 | 132157 | 4 |
0.220 | 82155 | 7 |
0.225 | 31604 | 3 |
0.230 | 33834 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online